Validation of a Prediction Model for Low Volume/Low Grade Cancer: Application in Selecting Patients for Active Surveillance
Author:
Affiliation:
1. Department of Urology, University of Texas, M.D. Anderson Cancer Center, Houston, Texas
2. Department of Pathology and Laboratory Medicine, Calgary Laboratory Service
3. Department of Urology, University of Calgary, Calgary, Alberta, Canada
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference20 articles.
1. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N Engl J Med,1991
2. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control;Weir;J Natl Cancer Inst,2003
3. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy;Babaian;J Urol,2000
4. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?;Chan;J Urol,2001
5. Twelve prostate biopsies detect significant cancer volumes (> 0.5 mL);Brossener;BJU Int,2000
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance;World Journal of Urology;2019-06-13
2. Neoplasms of the Prostate;Holland-Frei Cancer Medicine;2017-02-26
3. Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?;BJU International;2014-12-15
4. Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance;Urologic Oncology: Seminars and Original Investigations;2013-10
5. The Risk of Upstaged Disease Increases with Body Mass Index in Low-Risk Prostate Cancer Patients Eligible for Active Surveillance;European Urology;2012-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3